If one wanted to be an optimist about our S/C chances this morning, one could look at the Relief Therapeutics press release. While we can’t compare our trial to theirs, and we can’t assume a few bullet points tell the whole picture, the placebo arm of their critical patients performed very poorly. Only 17% were alive after 60 days out of 24 patients, apparently. Now, if you’re feeling optimistic like I said, consider how many of the 65 or so placebo patients in our trial would have passed away at that same rate. You could improve the success rate of placebo quite a bit (due to standard of care improving) and still come out with a big chunk of the 45 (or 50 or 35) deaths falling in the placebo arm. We can’t really compare but we can consider that between our EIND and these Relief results it’s not out of the equation. I remain confident of statistically significant results.